U. Krishnaja

From receptor biology to therapy: importance of different EGFR mutations in the development of targeted cancer therapies.

Cancer is a leading cause of death globally, and traditional therapies including chemotherapy and radiotherapy are often constrained by systemic toxicity and lack of specificity. Thus, targeted therapies are the need of the hour to revolutionize cancer treatment by enhancing specificity and selectivity, and minimizing...